Pfizer Inc. (NYSE:PFE) is featured among the 10 Highest Dividend-Paying Stocks to Invest in the S&P 500.
Pfizer Inc. (NYSE:PFE) stands as a leading name in the pharmaceutical and biotechnology sectors, offering a broad array of products and services. Recently, the company has actively sought to enhance its drug portfolio, highlighted by its significant $43 billion acquisition of Seagen, a company specializing in cancer treatment. Pfizer is also looking to expand its GLP-1 offerings, recently announcing a $4.9 billion cash acquisition of Metsera, a firm focused on innovative weight management therapies.
While the success of these new products in clinical trials remains uncertain, Metsera’s developments cater to a thriving segment in the GLP-1 market. With strong core business fundamentals, Pfizer Inc. (NYSE:PFE) positions itself as a compelling long-term stock option.
Recognized as one of the top dividend stocks, Pfizer has increased its dividend payouts for 15 consecutive years. It currently provides a quarterly dividend of $0.43 per share, yielding 7.24% as of September 27.
Although we see potential in PFE as an investment, there are certain AI-focused companies that may offer greater growth potential with reduced risk exposure. For those interested in a profoundly undervalued AI stock poised to benefit from the return of jobs to the U.S. and evolving tariffs, check out our free report on the best short-term AI stock.
READ NEXT: Dividend Capture Strategy: 15 High Yield Stocks to Buy in October and 10 Cash-Rich Dividend Stocks to Invest in Right Now.
Disclosure: None.
